Cytosorbents Corp reports results for the quarter ended June 30 - Earnings Summary
Cytosorbents Corp reports results for the quarter ended June 30 - Earnings Summary
Cytosorbents Corp CTSO.OQ reported a quarterly adjusted loss of 7 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 3 cents. The mean expectation of two analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -5 cents to -4 cents per share.
Revenue rose 0.2% to $9.63 million from a year ago; analysts expected $9.35 million.
Cytosorbents Corp's reported EPS for the quarter was a loss of 7 cents.
The company reported a quarterly loss of $4.42 million.
Cytosorbents Corp shares had risen by 2.9% this quarter and lost 39.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 10% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Cytosorbents Corp is $2.88, about 86.1% above its last closing price of $0.40
This summary was machine generated from LSEG data August 6 at 10:40 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.04 | -0.07 | Missed |
Mar. 31 2026 | -0.05 | -0.08 | Missed |
Dec. 31 2025 | -0.05 | -0.09 | Missed |
Sep. 30 2025 | -0.05 | -0.05 | Met |